Web Results

law.justia.com/cases/federal/district-courts/delaware/dedce/1:2017cv00210/61495/97

May 21, 2018 ... Purdue Pharma L.P. et al v. Amneal Pharmaceuticals, LLC, No. 1:2017cv00210 - Document 97 (D. Del. 2018) case opinion from the District of ...

law.justia.com/cases/federal/district-courts/delaware/dedce/1:2013cv01987/53754/431

Idenix Pharmaceuticals LLC et al v. Gilead Sciences Inc. et al, No. 1: 2013cv01987 - Document 431 (D. Del. 2016) case opinion from the District of Delaware US ...

www.federalregister.gov/documents/2018/04/11/2018-07440/oxford-pharmaceuticals-llc-et-al-withdrawal-of-approval-of-18-abbreviated-new-drug-applications

Apr 11, 2018 ... The Food and Drug Administration (FDA or Agency) is withdrawing approval of 18 abbreviated new drug applications (ANDAs) from multiple ...

tsi.brooklaw.edu/cases/allergan-inc-v-merz-pharmaceuticals-llc-et-al

Mar 18, 2011 ... Allergan, Inc., makers of the famous anti-wrinkle medication Botox, successfully obtained an injunction against the release of its competitor ...

www.law360.com/cases/507dc4c2d347233cde004332/articles

Coverage of federal case FERA Pharmaceuticals, LLC v. Akorn, Inc. et al, case number 1:12-cv-07694, from New York Southern Court.

www.uscourts.gov/file/13720/download

Mar 24, 2009 ... 440. GRAY v. DISTRICT OF COLUMBIA et al. MOTION for Summary Judgment. 08/17/2008. B ...... E8 Pharmaceuticals LLC et al v. Affymetrix ...